Partnership Programs for Reducing Cardiovascular Disparities in Native Hawaiians
The recruitment status of this study is unknown because the information has not been verified recently.
Verified July 2009 by National Heart, Lung, and Blood Institute (NHLBI).
Recruitment status was Recruiting
Recruitment status was Recruiting
Sponsor:
Information provided by:
National Heart, Lung, and Blood Institute (NHLBI)
ClinicalTrials.gov Identifier:
NCT00101465
First received: January 10, 2005
Last updated: July 28, 2009
Last verified: July 2009
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this study is to improve cardiovascular disease (CVD) outcomes in racial and ethnic minorities in Hawaii.
| Condition |
|---|
|
Cardiovascular Diseases Heart Diseases |
| Study Type: | Observational |
| Study Design: | Observational Model: Cohort Time Perspective: Prospective |
| Official Title: | Partnership Programs to Reduce Cardiovascular Disparities - Heart Failure Disparities in Native Hawaiians |
Resource links provided by NLM:
Further study details as provided by National Heart, Lung, and Blood Institute (NHLBI):
Eligibility| Ages Eligible for Study: | 21 Years to 90 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
Study Population
Participants will be a Native Hawaiian or Pacific Islander (e.g., Samoan, Tongan, Tahitian, Maori, Marshallese, etc.)
Criteria
Inclusion Criteria:
Clinical symptoms and signs of heart failure AND
- Left ventricular systolic ejection fraction of less than 40% OR
- Left ventricular systolic ejection fraction of less than 60% AND evidence of abnormal diastolic function confirmed by echocardiogram and documented in the patient's medical record
- Discharged from a hospital admission for heart failure as a primary or secondary discharge diagnosis within 6 weeks of study entry
- Self-identified ethnicity/race as Native Hawaiian or Pacific Islander (e.g., Samoan, Tongan, Tahitian, Maori, Marshallese, etc.)
Exclusion criteria
- Heart failure caused by high-output states (i.e., sepsis, etc.) or transient non-cardiac disease
- Terminal illnesses in addition to heart failure (e.g., cancer with projected survival of less than 6 months)
- Currently living in a nursing home
- Currently undergoing hemodialysis or peritoneal dialysis
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00101465
Contacts
| Contact: Nobumi Nakamura | puuwai@hawaii.edu |
Locations
| United States, Hawaii | |
| University of Hawaii at Manoa | Recruiting |
| Honolulu, Hawaii, United States, 96822 | |
| Principal Investigator: Marjorie Mau | |
| Queen's Medical Center | Recruiting |
| Honolulu, Hawaii, United States, 96813 | |
| Principal Investigator: Todd Seto | |
Sponsors and Collaborators
Investigators
| Principal Investigator: | Marjorie Mau | University of Hawaii at Manoa |
| Principal Investigator: | Todd Seto | Queen's Medical Centre |
More Information
No publications provided
| Responsible Party: | Nobumi Nakamura, University of Hawaii at Manoa |
| ClinicalTrials.gov Identifier: | NCT00101465 History of Changes |
| Other Study ID Numbers: | 1281, U01 HL79163 |
| Study First Received: | January 10, 2005 |
| Last Updated: | July 28, 2009 |
| Health Authority: | United States: Federal Government |
Keywords provided by National Heart, Lung, and Blood Institute (NHLBI):
|
Heart Failure |
Additional relevant MeSH terms:
|
Cardiovascular Diseases Heart Diseases Heart Failure |
ClinicalTrials.gov processed this record on May 23, 2013